Zain Bassam Mohammad DARDAS
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 63 | 0.930 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2024 | 119 | 0.910 |
Why?
|
| Heterotaxy Syndrome | 1 | 2024 | 62 | 0.870 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 132 | 0.830 |
Why?
|
| Translocation, Genetic | 1 | 2024 | 351 | 0.800 |
Why?
|
| Dysferlin | 1 | 2020 | 3 | 0.690 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 52 | 0.670 |
Why?
|
| Retinal Dystrophies | 3 | 2021 | 9 | 0.510 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 1806 | 0.490 |
Why?
|
| Membrane Transport Proteins | 2 | 2024 | 177 | 0.400 |
Why?
|
| Consanguinity | 3 | 2020 | 107 | 0.360 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2024 | 485 | 0.300 |
Why?
|
| Jordan | 4 | 2020 | 12 | 0.300 |
Why?
|
| Mutation | 7 | 2024 | 5771 | 0.270 |
Why?
|
| Pedigree | 5 | 2021 | 1583 | 0.260 |
Why?
|
| Phenotype | 6 | 2024 | 4227 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2024 | 118 | 0.230 |
Why?
|
| Arteries | 1 | 2024 | 222 | 0.210 |
Why?
|
| Genetic Variation | 2 | 2020 | 1479 | 0.210 |
Why?
|
| Gene Rearrangement | 1 | 2024 | 326 | 0.200 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2022 | 5 | 0.200 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2022 | 22 | 0.200 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2024 | 574 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 73 | 0.190 |
Why?
|
| Scimitar Syndrome | 1 | 2022 | 52 | 0.190 |
Why?
|
| Exome | 3 | 2021 | 1041 | 0.190 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2022 | 141 | 0.190 |
Why?
|
| T-Box Domain Proteins | 1 | 2022 | 122 | 0.190 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2022 | 122 | 0.180 |
Why?
|
| Malabsorption Syndromes | 1 | 2020 | 37 | 0.170 |
Why?
|
| Cystic Fibrosis | 1 | 2022 | 257 | 0.170 |
Why?
|
| Biliary Atresia | 1 | 2022 | 186 | 0.170 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 964 | 0.170 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 699 | 0.160 |
Why?
|
| Retinitis Pigmentosa | 1 | 2020 | 86 | 0.160 |
Why?
|
| Software | 1 | 2024 | 677 | 0.160 |
Why?
|
| Genetic Markers | 1 | 2021 | 609 | 0.160 |
Why?
|
| Crohn Disease | 1 | 2022 | 283 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 243 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2020 | 187 | 0.160 |
Why?
|
| Receptor, Notch1 | 1 | 2019 | 66 | 0.160 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 939 | 0.160 |
Why?
|
| Diarrhea | 1 | 2020 | 316 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 73 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 382 | 0.150 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 87 | 0.150 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 183 | 0.140 |
Why?
|
| Genetic Testing | 2 | 2022 | 995 | 0.140 |
Why?
|
| Humans | 16 | 2024 | 123184 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 3083 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2020 | 847 | 0.130 |
Why?
|
| Female | 10 | 2024 | 65494 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1043 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2020 | 1019 | 0.120 |
Why?
|
| Male | 9 | 2024 | 60083 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1116 | 0.110 |
Why?
|
| DNA | 1 | 2018 | 1592 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1530 | 0.100 |
Why?
|
| Young Adult | 3 | 2021 | 8885 | 0.100 |
Why?
|
| Adult | 6 | 2024 | 29065 | 0.100 |
Why?
|
| Adolescent | 4 | 2024 | 19118 | 0.090 |
Why?
|
| Homozygote | 2 | 2024 | 533 | 0.090 |
Why?
|
| Child | 4 | 2024 | 24244 | 0.080 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 761 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 793 | 0.070 |
Why?
|
| Animals | 2 | 2024 | 33714 | 0.070 |
Why?
|
| Ethanolamine | 1 | 2024 | 8 | 0.060 |
Why?
|
| Choline | 1 | 2024 | 55 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 2024 | 104 | 0.060 |
Why?
|
| Genotype | 2 | 2020 | 2539 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2022 | 26 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 22 | 0.050 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 45 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 42 | 0.050 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2022 | 5 | 0.050 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2022 | 13 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 83 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2024 | 185 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 115 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 531 | 0.050 |
Why?
|
| Fundus Oculi | 1 | 2020 | 63 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 26002 | 0.040 |
Why?
|
| Electroretinography | 1 | 2020 | 116 | 0.040 |
Why?
|
| Alleles | 1 | 2024 | 1603 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 543 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2020 | 223 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 572 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2019 | 289 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 235 | 0.040 |
Why?
|
| Binding Sites | 1 | 2020 | 1291 | 0.040 |
Why?
|
| Infant | 2 | 2024 | 12347 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 13889 | 0.040 |
Why?
|
| Family | 1 | 2020 | 581 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 673 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2020 | 807 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 516 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 2047 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 2584 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4707 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8106 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 17486 | 0.020 |
Why?
|